• Record: found
  • Abstract: found
  • Article: not found

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.


Amino Acid Sequence, Amyotrophic Lateral Sclerosis, enzymology, genetics, Animals, Base Sequence, Codon, DNA, Exons, Genome, Human, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymerase Chain Reaction, methods, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Sequence Homology, Amino Acid, Superoxide Dismutase

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


      Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.

      Related collections

      Author and article information



      Comment on this article